Reports covered in today’s news commentary include: Prostate cancer diagnosis in men of low socioeconiomic status The commercial launch of a new gene expression test Risks for secondary cancers following different types of radiation therapy Adverse effects of brachytherapy with or without hormone ablation Single-port, robot-assisted laparoscopic radical prostatectomy ARQ 501, a preclinical agent for potential [...]
Filed under: Diagnosis, Drugs in development, Management, Treatment | Tagged: ARQ501, Clarient, gene expression test, low socioeconomic status, radiation therapy, RALP, secondary cancer, single-port, stage | 4 Comments »
Search for new and
ongoing trials on the
CTAG PCa web site
